Clinical Trial Update: Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating thoracic radiotherapy with atezolizumab for extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer Extensive Stage

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Small Cell Lung Cancer Extensive Stage, Thoracic Radiotherapy | Phase 2 | Status: COMPLETED